Phil Gutry - Net Worth and Insider Trading
Phil Gutry Net Worth
The estimated net worth of Phil Gutry is at least $136,260 dollars as of 2024-11-05. Phil Gutry is the CHIEF BUSINESS OFFICER of Graphite Bio Inc and owns about 42,849 shares of Graphite Bio Inc (GRPH) stock worth over $136,260. Details can be seen in Phil Gutry's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Phil Gutry has not made any transactions after 2022-04-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Phil Gutry
Phil Gutry Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Phil Gutry owns 2 companies in total, including Avalo Therapeutics Inc (AVTX) , and Graphite Bio Inc (GRPH) .
Click here to see the complete history of Phil Gutry’s form 4 insider trades.
Insider Ownership Summary of Phil Gutry
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2015-10-14 | director |
| GRPH | Graphite Bio Inc | 2022-04-11 | CHIEF BUSINESS OFFICER |
Phil Gutry Latest Holdings Summary
Phil Gutry currently owns a total of 1 stock. Phil Gutry owns 42,849 shares of Graphite Bio Inc (GRPH) as of April 11, 2022, with a value of $136,260.
Latest Holdings of Phil Gutry
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GRPH | Graphite Bio Inc | 2022-04-11 | 42,849 | 3.18 | 136,260 |
Holding Weightings of Phil Gutry
Phil Gutry Form 4 Trading Tracker
According to the SEC Form 4 filings, Phil Gutry has made a total of 1 transactions in Graphite Bio Inc (GRPH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Graphite Bio Inc is the acquisition of 714 shares on April 11, 2022, which cost Phil Gutry around $20,050.
Insider Trading History of Phil Gutry
- 1
Phil Gutry Trading Performance
GuruFocus tracks the stock performance after each of Phil Gutry's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Phil Gutry is -22.06%. GuruFocus also compares Phil Gutry's trading performance to market benchmark return within the same time period. The performance of stocks bought by Phil Gutry within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Phil Gutry's insider trading performs compared to the benchmark.
Performance of Phil Gutry
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -43.63 | | | | | |
| Relative Return to S&P 500(%) | -32.81 | | | | | |
Phil Gutry Ownership Network
Ownership Network List of Phil Gutry
Ownership Network Relation of Phil Gutry
Phil Gutry Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Phil Gutry is the director of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Phil Gutry made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 99,840 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 435 shares were bought by its insiders, resulting in a net sale of 14,913 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
Phil Gutry Mailing Address
Above is the net worth, insider trading, and ownership report for Phil Gutry. You might contact Phil Gutry via mailing address: 400 E. Pratt Street, Suite 606, Baltimore Md 21202.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
